- Home
- MIRA vs NCRA Comparison
MIRA vs NCRA Comparison
Compare MIRA & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- NCRA
- Stock Information
- Founded
- MIRA 2020
- NCRA 2002
- Country
- MIRA United States
- NCRA Taiwan
- Employees
- MIRA N/A
- NCRA N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- MIRA Health Care
- NCRA Consumer Staples
- Exchange
- MIRA Nasdaq
- NCRA Nasdaq
- Market Cap
- MIRA 17.1M
- NCRA 15.4M
- IPO Year
- MIRA 2023
- NCRA N/A
- Fundamental
- Price
- MIRA $1.47
- NCRA $1.03
- Analyst Decision
- MIRA Strong Buy
- NCRA
- Analyst Count
- MIRA 2
- NCRA 0
- Target Price
- MIRA $14.00
- NCRA N/A
- AVG Volume (30 Days)
- MIRA 3.6M
- NCRA 17.2K
- Earning Date
- MIRA 11-12-2024
- NCRA 08-14-2024
- Dividend Yield
- MIRA N/A
- NCRA N/A
- EPS Growth
- MIRA N/A
- NCRA N/A
- EPS
- MIRA N/A
- NCRA N/A
- Revenue
- MIRA N/A
- NCRA $26,403,874.00
- Revenue This Year
- MIRA N/A
- NCRA N/A
- Revenue Next Year
- MIRA N/A
- NCRA N/A
- P/E Ratio
- MIRA N/A
- NCRA N/A
- Revenue Growth
- MIRA N/A
- NCRA 33.73
- 52 Week Low
- MIRA $0.51
- NCRA $0.73
- 52 Week High
- MIRA $6.40
- NCRA $1.54
- Technical
- Relative Strength Index (RSI)
- MIRA 48.43
- NCRA 45.69
- Support Level
- MIRA $1.65
- NCRA $0.99
- Resistance Level
- MIRA $1.75
- NCRA $1.10
- Average True Range (ATR)
- MIRA 0.33
- NCRA 0.13
- MACD
- MIRA -0.03
- NCRA -0.02
- Stochastic Oscillator
- MIRA 13.01
- NCRA 14.50
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.